Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Vivus readies NDA as Ph3 trial hits goals for ED drug
Fierce Biotech
Wednesday, May 25, 2011 - 11:39am
tags:
Vivus, erectile dysfunction, Avanafil
Novartis’s Gilenya MS Drug Has 10,000 Users in U.S., Mundel Says
Bloomberg
Wednesday, May 25, 2011 - 11:34am
tags:
Novartis, MS, Gilenya, multiple sclerosis
AMRI receiving $3M milestone payment from Bristol-Myers
Bizjournals.com
Wednesday, May 25, 2011 - 11:32am
tags:
milestone payments, AMRI, Bristol-Myers Squibb, CNS triple reuptake transporter inhibitors
Celgene's Management Is Creating Value
Motley Fool
Wednesday, May 25, 2011 - 11:29am
tags:
Celgene
SEC May Let Whistle-blowers Bypass Internal Complaint Systems
Bloomberg
Wednesday, May 25, 2011 - 11:29am
tags:
SEC, whistleblowers
Ardea Biosciences Evenly Poised
Yahoo/Zacks.com
Wednesday, May 25, 2011 - 9:50am
tags:
Ardea, HIV, cancer, gout
Avanir: Congress Gripes About High Drug Price
TheStreet.com
Wednesday, May 25, 2011 - 9:48am
tags:
congress, drug prices, Avanir, Nuedexta, PBA
Senate Panel Hits Sanofi Payments
WSJ Online
Wednesday, May 25, 2011 - 9:46am
tags:
Senate, Sanofi, Lovenox
Roche Leads Deadly Skin Cancer Turnaround as Dozen Drugs Coming
Bloomberg
Wednesday, May 25, 2011 - 9:28am
tags:
Roche, skin cancer, melanoma, vemurafenib, GSK, Bristol-Myers Squibb, Daiichi Sankyo, Yervoy
Bayer, J&J’s Xarelto Prevented Repeat Strokes in Analysis
Bloomberg
Wednesday, May 25, 2011 - 9:26am
tags:
JNJ, Bayer, stroke, Xarelto
Novartis Says Experimental Gout Drug is Effective
WSJ Online
Wednesday, May 25, 2011 - 9:21am
tags:
gout, Novartis, Ilaris
FTC Challenges Pay-To-Delay In Court Filing
Pharmalot
Wednesday, May 25, 2011 - 8:07am
tags:
pay-for-delay, FTC
The Name Game: Why Pfizer’s Generic Version of Viagra Will Be Renamed “Avigra”
BNET Pharma
Wednesday, May 25, 2011 - 8:05am
tags:
Pfizer, drug names, generics, patents, Viagra, erectile dysfunction, Viagra Jet, Avigra
If at First You Don't Succeed, Spin It Off: Lilly's Xigris
Motley Fool
Wednesday, May 25, 2011 - 8:03am
tags:
Eli Lilly, Xigris, sepsis, BioCritica
Somaxon Is a Sleeper in the Insomnia Market
Seeking Alpha
Wednesday, May 25, 2011 - 8:01am
tags:
insomnia, Somaxon, Silenor
Emerging-Markets Business Offsets Generics: Glaxo CEO
CNBC
Wednesday, May 25, 2011 - 7:59am
tags:
GSK, emerging markets, Andrew Witty
Vertex’s Sales Force Gears Up For ‘David vs. Goliath’ Marketing Push
WSJ Online
Tuesday, May 24, 2011 - 8:18pm
tags:
Vertex Pharmaceuticals, Merck, hepatitis C, Incivek, Victrelis
Risk-Reward Balanced at HGSI
Yahoo/Zacks.com
Tuesday, May 24, 2011 - 8:17pm
tags:
Human Genome Sciences, GSK, Novartis, lupus, Benlysta
J&J CEO Weldon Tells CNBC Consumers Remain ‘A Little Apprehensive’
Bloomberg
Tuesday, May 24, 2011 - 8:15pm
tags:
JNJ, recalls, William Weldon
[video] Mad Money Recap: Allergan
TheStreet.com
Tuesday, May 24, 2011 - 2:01pm
tags:
Allergan, Botox

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.